This study aims to explore the gene expression profiles in anti-RNP-positive SLE patients to identify the pathways that might differentiate them from other serotypes, potentially revealing novel insights into SLE pathogenesis. The gene discussed is RNPC3; the disease is systemic lupus erythematosus.